---
title: Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma
  used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
date: '2024-05-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38765202/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240520180926&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The deviations revealed the necessity of systematic trainings
  with appropriate feedback before the start of clinical trials in radiation oncology
  and the constant monitoring of protocol compliance throw-out the ...'
disable_comments: true
---
CONCLUSIONS: The deviations revealed the necessity of systematic trainings with appropriate feedback before the start of clinical trials in radiation oncology and the constant monitoring of protocol compliance throw-out the ...